A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer (Q46630304)
Jump to navigation
Jump to search
scientific article published in August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer |
scientific article published in August 2005 |
Statements
1 reference
A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer (English)
1 reference
Helen Mackay
1 reference
Pierre Major
1 reference
Carol Townsley
1 reference
Mary Mackenzie
1 reference
Mark Vincent
1 reference
Pam Degendorfer
1 reference
Trudey Nicklee
1 reference
Diana Birle
1 reference
John Wright
1 reference
Lillian Siu
1 reference
Malcolm Moore
1 reference
Amit Oza
1 reference
1 August 2005
1 reference
11
1 reference
15
1 reference
5526-5533
1 reference